Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
SYRE on Nasdaq
Jeffrey W. Albers - trading volume in the past year for Spyre Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
27.4K |
$1.01M |
$36.76 |
Nov 6, 2024 |
By Sessions LLC |
|
|
| Stock Option (Right to Buy) |
11.3K |
|
|
May 14, 2024 |
Direct |
Common Stock |
|
| Series A Preferred Stock |
0 |
|
|
Nov 24, 2023 |
By Sessions LLC |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.